Trial Profile
Combination therapy with azelnidipine or trichlormethiazide added on olmesartan in hypertensive patients with glucose intolerance
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Aug 2014
Price :
$35
*
At a glance
- Drugs Azelnidipine (Primary) ; Olmesartan medoxomil; Trichlormethiazide
- Indications Glucose intolerance; Hypertension
- Focus Therapeutic Use
- 19 Aug 2014 New trial record